Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Sales (2021)

Historic Return on Sales for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to 0.19%.

  • Atea Pharmaceuticals' Return on Sales rose 10400.0% to 0.19% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.19%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.34% for FY2021, which is 5700.0% up from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Return on Sales is 0.19%, which was up 10400.0% from 0.07% recorded in Q2 2022.
  • In the past 5 years, Atea Pharmaceuticals' Return on Sales registered a high of 0.61% during Q4 2021, and its lowest value of 0.86% during Q3 2021.